Lv5
906 积分 2021-03-16 加入
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor–independent pathways
14小时前
已完结
Analytical Development and Testing Strategy of Antibody–Drug Conjugates
1个月前
已完结
Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand
2个月前
已完结
FcRn: the neonatal Fc receptor comes of age
2个月前
已完结
Primary and secondary immune thrombocytopenia (ITP): Time for a rethink
2个月前
已完结
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: A systematic review and meta-analysis
5个月前
已完结
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
5个月前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
7个月前
已完结
Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
7个月前
已完结
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
7个月前
已完结
皖公网安备34019202002308
